eko.ai Pte. Ltd. d/b/a Us2.ai
About eko.ai Pte. Ltd. d/b/a Us2.ai
Us2.ai (formerly eko.ai Pte. Ltd.) is a Singapore-based healthcare AI company dedicated to transforming cardiovascular diagnostics through fully automated echocardiography analysis. Their FDA-cleared and CE-marked software platform, Us2.v1 and Us2.v2, leverages advanced machine learning and deep clinical expertise to process comprehensive echocardiographic studies, including 2D and Doppler images, from any vendor in less than two minutes. This technology delivers complete, structured echo reports with measurements, editable annotations, and conclusions for every heart chamber, significantly reducing reporting time and increasing daily scan throughput.
For physicians, Us2.ai offers a solution that goes beyond partial automation, providing zero-click analysis and eliminating measurement variability, while maintaining accuracy comparable to expert human sonographers. The platform supports the detection of various heart conditions, including cardiac amyloidosis, aortic stenosis, heart failure, and valvular disease, by combining AI pattern recognition with guideline-based measurements. This democratizes expert-level cardiac diagnostics, making echocardiography analysis faster, more accurate, and accessible, ultimately improving patient outcomes and expanding healthcare access globally.
Focus Areas
Business Intelligence
| Key Investors | IHH Healthcare, Heal Partners, Peak XV Partners (formerly Sequoia India), EDBI, Pappas Capital, Partech Ventures, SGInnovate, Bfa Global Investors, East Post Road Ventures, FJ Labs |
| Partnerships | AstraZeneca (research), Janssen (research), Duke University, Fujifilm, deepc, Harrison.ai, Merative Merge, Brigham & Women's Hospital, INFINITT North America, Lenus Health |
| Technology | Deep learning solutions, AI-powered, cloud-native, integrates with ultrasound devices and PACS, automated pattern recognition, guideline-based measurements, DICOM processing, real-time analysis |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
For physicians, Us2.ai offers significant time savings by reducing reporting time by up to 70% and increasing daily scan throughput, thereby freeing up valuable time for patient interaction and complex cases. The platform ensures improved accuracy and consistency through standardized, reproducible measurements, reducing inter-observer and intra-observer variability. It enhances clinical decision-making with guideline-directed, structured reporting, editable AI outputs, and disease-specific indications. The automation reduces workload and fatigue for sonographers and cardiologists by eliminating tedious manual tasks. Importantly, physicians retain final clinical authority with editable AI-generated drafts. The system also supports population health initiatives and screening by enabling efficient disease detection and follow-up, helping to lower patient backlogs.
Us2.ai is designed for seamless integration into existing hospital infrastructure and workflows. It connects to any ultrasound device, PACS, CVIS, or EMR via standard DICOM routing (ports 104/11112) and supports HL7 and DICOM SR for structured reports. Deployment can be cloud-based or on-premise, with minimal IT effort and no permanent infrastructure changes. Partnerships with companies like Merative (Merge Cardio), ASCEND Cardiovascular, and Aidoc (aiOS) further enhance its integration capabilities within broader cardiovascular imaging and AI platforms.
Reviews & Opinions
Videos
News, demos, and interviews about eko.ai Pte. Ltd. d/b/a Us2.ai.
Videos load interactively. If none appear, search YouTube for eko.ai Pte. Ltd. d/b/a Us2.ai →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]